PALBOCICLIB for Breast cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 13,075 adverse event reports in the FDA FAERS database where PALBOCICLIB was used for Breast cancer.
Most Reported Side Effects for PALBOCICLIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 15,190 | 16.7% | 522 | 1,889 |
| White blood cell count decreased | 11,273 | 12.4% | 420 | 1,505 |
| Neoplasm progression | 10,885 | 12.0% | 1,499 | 1,400 |
| Death | 8,410 | 9.2% | 8,384 | 556 |
| Nausea | 8,189 | 9.0% | 346 | 1,395 |
| Neutropenia | 6,423 | 7.1% | 313 | 759 |
| Alopecia | 6,201 | 6.8% | 137 | 619 |
| Diarrhoea | 5,635 | 6.2% | 187 | 983 |
| Asthenia | 3,660 | 4.0% | 320 | 920 |
| Off label use | 3,405 | 3.7% | 353 | 451 |
| Decreased appetite | 3,400 | 3.7% | 238 | 757 |
| Pain | 3,384 | 3.7% | 179 | 698 |
| Malaise | 3,294 | 3.6% | 199 | 710 |
| Dyspnoea | 3,178 | 3.5% | 304 | 1,116 |
| Vomiting | 3,060 | 3.4% | 236 | 929 |
Other Indications for PALBOCICLIB
Breast cancer metastatic (18,160)
Breast cancer female (17,915)
Product used for unknown indication (2,475)
Neoplasm malignant (1,996)
Breast cancer stage iv (1,232)
Metastases to bone (556)
Bone cancer (493)
Hormone receptor positive her2 negative breast cancer (386)
Invasive ductal breast carcinoma (332)
Breast cancer recurrent (318)
Other Drugs Used for Breast cancer
TRASTUZUMAB (15,522)
DOCETAXEL (11,735)
PACLITAXEL (10,215)
LETROZOLE (9,332)
CYCLOPHOSPHAMIDE (8,826)
PERTUZUMAB (7,532)
RIBOCICLIB (6,953)
CAPECITABINE (5,767)
EPIRUBICIN (5,444)
ABEMACICLIB (4,719)